PROPRIETARY ARGININE VASOPRESSIN RECEPTOR TYPE 1A (AVPR1A) ANTAGONISTS FOR TREATMENT OF LETHAL PROSTATE CANCER
$1,272,102FY2025Defense Health AgencyDOD
University Of Miami, Coral Gables FL
Investigators
View source on USAspending →PROPRIETARY ARGININE VASOPRESSIN RECEPTOR TYPE 1A (AVPR1A) ANTAGONISTS FOR TREATMENT OF LETHAL PROSTATE CANCER · GrantIndex